This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rengifo-Cam, W. Articles by Singh, P. Search for Related Content PubMed PubMed Citation Articles by Rengifo-Cam, W. Articles by Singh, P.

Antiapoptotic Effects of Progastrin on Pancreatic Cancer Cells Are Mediated by Sustained Activation of Nuclear Factor-B

Departments of ¹ Neuroscience and Cell Biology and ² Internal Medicine-Gastroenterology, University of Texas Medical Branch, Galveston, Texas

Requests for reprints: Pomila Singh, Department of Neuroscience and Cell Biology, University of Texas Medical Branch, 10.104 Medical Research Building, Route 1043, Galveston, TX 77555-1043. Phone: 409-772-4842; Fax: 409-772-3222; E-mail: posingh{at}utmb.edu.

Progastrin (PG) exerts proliferative and antiapoptotic effects on intestinal epithelial and colon cancer cells via Annexin II (ANX-II). In here, we show that ANX-II similarly mediates proliferative and antiapoptotic effects of PG on a pancreatic cancer cell line, AR42J. The role of several signaling molecules was examined in delineating the biological activity of PG. PG (0.1–1.0 nmol/L) caused a significant increase (2- to 5-fold) in the phosphorylation of phosphatidylinositol 3-kinase (PI3K), Akt (Thr³⁰⁸), p38 mitogen-activated protein kinase (MAPK; Thr¹⁸⁰/Tyr¹⁸²), extracellular signal-regulated kinases (ERK; Thr²⁰²/Tyr²⁰⁴), IB kinase /ß (IKK/ß; Ser¹⁷⁶/¹⁸⁰), IB (Ser³²), and p65 nuclear factor-B (NF-B; Ser⁵³⁶). Inhibition of p44/42 ERKs (PD98059), p38 MAPK (SB203580), Akt, and PI3K (LY294002), individually or combined, partially reversed antiapoptotic effects of PG. The kinetics of phosphorylation of IKK/ß in response to PG matched the kinetics of phosphorylation and degradation of IB and correlated with phosphorylation, nuclear translocation, and activation of p65 NF-B. NF-B essential modulator–binding domain peptide (an inhibitor of IKK/ß) effectively blocked the activity of p65 NF-B in response to PG. Activation of p65 NF-B, in response to PG, was 70% to 80% dependent on phosphorylation of MAPK/ERK and PI3K/Akt molecules. Down-regulation of p65 NF-B by specific small interfering RNA resulted in the loss of antiapoptotic effects of PG on AR42J cells. These studies show for the first time that the canonical pathway of activation of p65 NF-B mediates antiapoptotic effects of PG. Therefore, targeting PG and/or p65 NF-B may be useful for treating cancers, which are dependent on autocrine or circulating PGs for their growth. [Cancer Res 2007;67(15):7266–74]

This article has been cited by other articles:

				S. Umar, S. Sarkar, Y. Wang, and P. Singh Functional Cross-talk between {beta}-Catenin and NF{kappa}B Signaling Pathways in Colonic Crypts of Mice in Response to Progastrin J. Biol. Chem., August 14, 2009; 284(33): 22274 - 22284. [Abstract] [Full Text] [PDF]

				I. L P Beales and O. O Ogunwobi Glycine-extended gastrin inhibits apoptosis in Barrett's oesophageal and oesophageal adenocarcinoma cells through JAK2/STAT3 activation J. Mol. Endocrinol., April 1, 2009; 42(4): 305 - 318. [Abstract] [Full Text] [PDF]